Clinical Trials in Nashville

Showing 4721-4740 of 20,298 trials

Executive Function in Early Childhood

NCT03713125

Despite the fact that a substantial number of school age children struggle with both reading and math acquisition, the brain mechanisms of the overlapping aspects of reading and math skills, thought in part to be linked via executive functions (EF), have not been unpacked. This project will use a longitudinal design, following children from Kindergarten through 1st grade, to understand how the brain networks associated with reading, math, and EF interact to predict academic outcomes and, in those who struggle academically, intervention response.

Reading Disability

Vanderbilt University260 participantsStarted Aug 2019

Nashville, Tennessee, United States

Active Not RecruitingPhase 3< 1 mile

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

NCT05239728

The purpose of this study is to assess the efficacy and safety of oral belzutifan (MK-6482) plus intravenous (IV) pembrolizumab (MK-3475) compared to placebo plus pembrolizumab, in the adjuvant treatment of Clear Cell Renal Cell Carcinoma (ccRCC) post nephrectomy. The primary study hypothesis is that belzutifan plus pembrolizumab is superior to placebo plus pembrolizumab with respect to disease-free survival (DFS).

Carcinoma, Renal Cell

Merck Sharp & Dohme LLC1,800 participantsStarted Mar 2022

Phoenix, Arizona, United States • Duarte, California, United States • La Jolla, California, United States +282 more locations

Executive Function in Early Childhood

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Find Trials by Condition in Nashville

The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Actis Total Hip System 2 Year Follow-up

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population

Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease

Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Scaling Up Maternal Mental Healthcare by Increasing Access to Treatment (SUMMIT)

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

Topical ENS-002 for Atopic Dermatitis in Adults